Saturday, July 11, 2026

pharma · Severe Acute Respiratory Syndrome-related Coronavirus

Yang I. Pachankis

Yang I. Pachankis trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Trials

Yang I. Pachankis clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Yang I. Pachankis programs — each row shows trial ID, program name, phase, status, and indication.

Yang I. Pachankis trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Yang I. Pachankis.

  1. Nifedipine 30 MG — Approved

    Clinical update

Trial registry

1 studies